Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, September 16 at 2:00 PM EDT

Register Free →

This Solicitation opportunity from Department Of Defense was posted on May 18, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

GUAIFENESIN EXTENDE

Closed
SPE2DP-26-T-3451Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The contract calls for the delivery of 3 bulk units of Guaifenesin 600mg extended-release tablets, each containing 500 tablets, under solicitation SPE2DP-26-T-3451, with a mandatory delivery window of 20 days after award to Fort Bragg, North Carolina, under FOB Destination terms. The product must meet strict pharmaceutical standards, including a minimum 36-month shelf life from manufacture, with no less than 31 months remaining at the time of government receipt. Packaging must adhere to commercial specifications as defined in the procurement document, with each unit sealed in protective containers and shipped in durable exterior packaging suitable for safe transit via common carrier at the lowest possible rate, including export compliance when applicable. All markings must conform to Medical Marking Standard No. 1, which supersedes MIL-STD-129 for medical items, and preservation and packing must comply with MIL-STD-2073-1E. The item is regulated by the FDA, and the contracting official must submit a referral to confirm manufacturer and product details prior to award. The supplier must be registered in the System for Award Management and comply with all applicable DLA Technical and Quality Requirements, including those identified by R and I numbers referenced in the DLA Master List. The contract incorporates a comprehensive set of Federal Acquisition Regulation clauses governing quality assurance, transportation, cybersecurity, labor compliance, sustainable procurement, and hazardous material handling, with multiple deviations and alternates applied, particularly around safeguarding, changes, subcontracting, and information systems protection. All invoices must be submitted electronically via Wide Area WorkFlow, and no alternative invoicing methods are permitted. Inspection and acceptance occur at the delivery point, with government personnel responsible for verifying compliance with packaging, labeling, and shelf-life requirements. The solicitation explicitly prohibits the use of covered defense telecommunications equipment from prohibited entities and requires offerors to disclose their entity identifier, CAGE code, and size status, including any applicable socioeconomic certifications. The contract is issued under the Department of Defense’s Medical Supply Chain, with Morgan Kelly identified as the primary point of contact, and all administrative data including payment details, appropriation codes, and contracting officer assignments will be finalized upon award. The acquisition is treated as a simplified purchase without a specified contract type or pricing, and no evaluation factors or weights are outlined for award determination.

General Info

Procure 600mg guaifenesin tablets, 3 bottles, deliver to Fort Bragg within 20 days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSAView Agency

NAICS

325412 - Pharmaceutical Preparation ManufacturingView NAICS

Place of Performance

5234 EAGLE TALON DR BLDG X3063, FORT BRAGG, NC, 28310, USA

Set-Aside

NONE

Documents

(1)

RFQ SPE2DP-26-T-3451 Medical Supply Chain

PDFrfq

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
Contacts1 person available
OfficeUSA
Organization / Agency
Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA
View Agency Profile
Office AddressUSA

Full Description

Show more
GUAIFENESIN EXTENDE
GUAIFENESIN EXTENDED-RELEASE TABLETS,600MG, 500S
U/I "BT" (500'S)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
SHALL HAVE A SHELF LIFE OF 36 MONTHS.
NOT LESS THAN 31 MONTHS SHALL REMAIN FROM DATE OF MANUFACTURE TO DATE OF
DELIVERY TO THE GOVERNMENT.
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
INCLUDE R2660 OBJECT TEXT ID ST
This device or drug is regulated by the FDA. Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description.
SPE2DP-26-T-3451
SECTION B
RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
THE HARVARD DRUG GROUP, L.L.C. 1LEZ0 P/N NDC00904-6986-04 RECKITT BENCKISER LLC 0MWS8 P/N NDC63824-0008-50
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016814962 0001 BT 3.000
NSN/MATERIAL:6505013405446
DELIVERY (IN DAYS):0020
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-340-5446 Quantity: 3 BT Purchase Request: 7016814962QTY: 3 Delivery: 20 days ADO

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 650+ contractors already using CLEATUS